Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100(18):1872–8.
Article PubMed CAS Google Scholar
Waksman R, Steinvil A. In-stent restenosis? The raiders of the magic remedy. Circ Cardiovasc Interv. 2016;9(7).
Macander PJ, Roubin GS, Agrawal SK, Cannon AD, Dean LS, Baxley WA. Balloon angioplasty for treatment of in-stent restenosis: feasibility, safety, and efficacy. Catheter Cardiovasc Diagn. 1994;32(2):125–31.
Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56(23):1897–907.
Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–23.
Article PubMed CAS Google Scholar
Farooq V, Gogas BD, Serruys PW. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv. 2011;4(2):195–205.
Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart. 2014;100(2):153–9.
Yerasi C, Case BC, Forrestal BJ, Torguson R, Weintraub WS, Garcia-Garcia HM, et al. Drug-coated balloon for De novo coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(9):1061–73.
Article PubMed CAS Google Scholar
Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355(20):2113–24.
Article PubMed CAS Google Scholar
Giacoppo D, Gargiulo G, Aruta P, Capranzano P, Tamburino C, Capodanno D. Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. Bmj. 2015;351:h5392.
Article PubMed PubMed Central Google Scholar
Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
Bhatt DL. Percutaneous coronary intervention in 2018. Jama. 2018;319(20):2127–8.
Jackson D, Tong D, Layland J. A review of the coronary applications of the drug coated balloon. Int J Cardiol. 2017;226:77–86.
Kereiakes DJ, Kandzari DE, Zidar JP. Drug-coated balloons for in-stent restenosis. J Am Coll Cardiol. 2020;76(11):1391–2.
Article PubMed CAS Google Scholar
Singh AD, Singal AK, Mian A, Kapadia SR, Hedrick DP, Kanaa NA, et al. Recurrent drug-eluting stent in-stent restenosis: a state-of-the-art review of pathophysiology, diagnosis, and management. Cardiovasc Revasc Med. 2020;21(9):1157–63.
Ozawa M, Okamura A, Date M, Higuchi Y, Nagai H, Shibuya M, et al. Third in-stent restenosis in sirolimus eluting stents: predictors of the next restenosis. Catheter Cardiovasc Interv. 2012;79(1):91–6.
Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150–e62.
Article PubMed PubMed Central Google Scholar
Cheng G, Chang FJ, Wang Y, You PH, Chen HC, Han WQ, et al. Factors influencing stent restenosis after percutaneous coronary intervention in patients with coronary heart disease: a clinical trial based on 1-year follow-up. Med Sci Monit. 2019;25:240–7.
Article PubMed PubMed Central CAS Google Scholar
Wan YL, Tsay PK, Chen CC, Juan YH, Huang YC, Chan WH, et al. Coronary in-stent restenosis: predisposing clinical and stent-related factors, diagnostic performance and analyses of inaccuracies in 320-row computed tomography angiography. Int J Cardiovasc Imaging. 2016;32(Suppl 1):105–15.
Shlofmitz E, Khalid N, Waksman R. In-stent restenosis: a second chance to get it right. J Am Coll Cardiol. 2020;76(11):1389–90.
Kleber FX, Rittger H, Bonaventura K, Zeymer U, Wöhrle J, Jeger R, et al. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol. 2013;102(11):785–97.
Article PubMed CAS Google Scholar
Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619.
Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García del Blanco B, García-Touchard A, López-Minguéz JR, et al. A prospective randomized trial of drug-eluting balloons versus Everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial. J Am Coll Cardiol. 2015;66(1):23–33.
Article PubMed CAS Google Scholar
Rosenberg M, Waliszewski M, Chin K, Ahmad W, Caramanno G, Milazzo D, et al. Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: the DCB-only all-comers registry. Catheter Cardiovasc Interv. 2019.
Cho JY. Identification of risk factors influencing in-stent restenosis with acute coronary syndrome presentation. Chonnam Med J. 2017;53(3):203–10.
Article PubMed PubMed Central CAS Google Scholar
Bhatnagar A, Maziak W, Eissenberg T, Ward KD, Thurston G, King BA, et al. Water pipe (hookah) smoking and cardiovascular disease risk: a scientific statement from the American Heart Association. Circulation. 2019;139(19):e917–e36.
Article PubMed PubMed Central Google Scholar
Qin SY, Zhou Y, Jiang HX, Hu BL, Tao L, Xie MZ. The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis. PLoS One. 2013;8(9):e72710.
Article PubMed PubMed Central CAS Google Scholar
Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.
Tocci G, Barbato E, Coluccia R, Modestino A, Pagliaro B, Mastromarino V, et al. Blood pressure levels at the time of percutaneous coronary revascularization and risk of coronary in-stent restenosis. Am J Hypertens. 2016;29(4):509–18.
Article PubMed CAS Google Scholar
Wilson S, Mone P, Kansakar U, Jankauskas SS, Donkor K, Adebayo A, et al. Diabetes and restenosis. Cardiovasc Diabetol. 2022;21(1):23.
Article PubMed PubMed Central CAS Google Scholar
Mone P, Gambardella J, Minicucci F, Lombardi A, Mauro C, Santulli G. Hyperglycemia drives stent restenosis in STEMI patients. Diabetes Care. 2021;44(11):e192–e3.
Article PubMed PubMed Central Google Scholar
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018;17(1):83.
Article PubMed PubMed Central Google Scholar
Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep. 2019;21(4):21.
Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, et al. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes. 1993;42(1):80–9.
Article PubMed CAS Google Scholar
Stocca A, O'Toole D, Hynes N, Hynes SO, Mashayekhi K, McGinley L, et al. A role for MRP8 in in stent restenosis in diabetes. Atherosclerosis. 2012;221(2):325–32.
Article PubMed CAS Google Scholar
Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667–78.
Article PubMed CAS Google Scholar
Ferreira IA, Mocking AI, Feijge MA, Gorter G, van Haeften TW, Heemskerk JW, et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2006;26(2):417–22.
Article PubMed CAS Google Scholar
Faries PL, Rohan DI, Takahara H, Wyers MC, Contreras MA, Quist WC, et al. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg. 2001;33(3):601–7.
留言 (0)